The trial of early administration of pregaablin for post operative thoracotomy pain

The trial of early administration of pregaablin for post operative thoracotomy pain - The trial of early administration of pregaablin for post operative thoracotomy pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012386

Enrollment

100

Registered

2013-11-25

Start date

2013-11-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

control group celecoxib 400 mg daily ropivacaine for epidural ansethesia Taking pregabalin on postoperative days to 14 days after operation (150mg/ daily)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: lung cancer patients PS 0 or 1 Communicatable

Exclusion criteria

Exclusion criteria: renal dysfunction intake of some analgesia preoperatively history of thoracotomy median sternotomy Extraplueral pneumonectomy, pleural biopsy, mediastinal tumor severe complication including, heart,pulmonary,liver and diabetes mellitus and so on not appropriate for epidural anesthesia pregnancy pluerodesis

Design outcomes

Primary

Measure	Time frame
The total amount of additional analgesics in hospital	—

Secondary

Measure	Time frame
1 Numeric rating scale 2 The rate of adverse effect 3 The incidence of post thoracotomy pain syndrome 4 Pain detect qustionnaire 5 Pain Catastrophizing Scale	—

Countries

Japan

Contacts

Public ContactTakuro Miyazaki

Nagasaki University Graduate School of Medicine Surgical Oncology

miyataku@nagasaki-u.ac.jp095-819-7304

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026